Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
Diseases of the central nervous system (CNS) have historically been among the most difficult to treat using conventional pharmacological approaches. This is due to a confluence of factors, including the limited regenerative capacity and overall complexity of the brain, problems associated with repea...
Main Authors: | Joseph Edward Rittiner, Malik Moncalvo, Ornit Chiba-Falek, Boris Kantor |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2020.00148/full |
Similar Items
-
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
by: Wendy Dong, et al.
Published: (2021-07-01) -
The development of a viral mediated CRISPR/Cas9 system with doxycycline dependent gRNA expression for inducible in vitro and in vivo genome editing.
by: Christopher A. de Solis, et al.
Published: (2016-08-01) -
Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease
by: Misha Angrist, et al.
Published: (2020-10-01) -
Viral Cre-LoxP tools aid genome engineering in mammalian cells
by: Ranjita Sengupta, et al.
Published: (2017-11-01) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
by: Ariel Kantor, et al.
Published: (2020-08-01)